These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2444154)

  • 1. Neutralizing antibody to the AIDS virus. Prevalence, clinical significance and virus strain specificity.
    Prince AM; Pascual D; Bardina-Kosolopov L; Kurokawa D; Baker L; Rubinstein P
    Antibiot Chemother (1971); 1987; 38():151-8. PubMed ID: 2444154
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus.
    Prince AM; Pascual D; Kosolapov LB; Kurokawa D; Baker L; Rubinstein P
    J Infect Dis; 1987 Aug; 156(2):268-72. PubMed ID: 3474300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.
    Vujcic LK; Shepp DH; Klutch M; Wells MA; Hendry RM; Wittek AE; Krilov L; Quinnan GV
    J Infect Dis; 1988 May; 157(5):1047-50. PubMed ID: 3162928
    [No Abstract]   [Full Text] [Related]  

  • 4. Human retrovirus infection and immunodeficiencies. Detection and significance of virus-neutralizing antibodies.
    Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Francavilla E; Amadori A; Chieco-Bianchi L
    Antibiot Chemother (1971); 1987; 38():159-66. PubMed ID: 3662468
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of serum neutralization response to the human immunodeficiency virus (HIV).
    Groopman JE; Benz PM; Ferriani R; Mayer K; Allan JD; Weymouth LA
    AIDS Res Hum Retroviruses; 1987; 3(1):71-85. PubMed ID: 2441727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
    McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
    Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status and problems of AIDS screening tests].
    Tamagawa S; Mizuoka K
    Rinsho Byori; 1987 Oct; 35(10):1123-8. PubMed ID: 3481415
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of an AIDS vaccine: a daunting epidemiological challenge.
    Nathanson N; Mathieson BJ
    Eur J Epidemiol; 2005; 20(2):123-6. PubMed ID: 15792276
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
    Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
    Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody test for AIDS. Uses and limitations.
    Gauthier DK; Turner JG
    AAOHN J; 1988 Jul; 36(7):266-73. PubMed ID: 3382473
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a commercial ELISA test for the diagnosis of infection by the AIDS virus, HIV, in a patient population.
    Johnson JE
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):267-71. PubMed ID: 3471372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus antibody testing: time for clinicians to use it.
    deHovitz JA; Landesman SH
    N Y State J Med; 1988 May; 88(5):217-8. PubMed ID: 3164100
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of HIV envelope specific antibodies by immunoelectron microscopy and correlation with antibody titer and virus neutralizing activity.
    Hausmann EH; Gelderblom HR; Clapham PR; Pauli G; Weiss RA
    J Virol Methods; 1987 May; 16(1-2):125-37. PubMed ID: 3038935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal serologic evaluation of an infant with acquired immunodeficiency syndrome.
    Krilov LR; Kamani N; Hendry RM; Wittek AE; Quinnan GV
    Pediatr Infect Dis J; 1987 Nov; 6(11):1066-7. PubMed ID: 3480501
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody response in primary human immunodeficiency virus infection.
    Gaines H; von Sydow M; Sönnerborg A; Albert J; Czajkowski J; Pehrson PO; Chiodi F; Moberg L; Fenyö EM; Asjö B
    Lancet; 1987 May; 1(8544):1249-53. PubMed ID: 2884379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological study of subjects with seroconversion to human immunodeficiency virus.
    Re MC; Furlini G; Baldassarri B; Chiodo F
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):144-8. PubMed ID: 3134201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dot enzyme immunoassay. A simple, cheap and stable test for antibody to human immunodeficiency virus (HIV).
    Ivo dos Santos J; Galvao-Castro B; Mello DC; Pereira HG; Pereira MS
    J Immunol Methods; 1987 May; 99(2):191-4. PubMed ID: 3295054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC of AIDS. The virus and the tests.
    Mortimer PP
    Br Med J (Clin Res Ed); 1987 Jun; 294(6587):1602-5. PubMed ID: 3113548
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
    Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
    Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.